RCEP, covering 30% of global GDP, is Asia’s strongest institutional shield against trade disruptions like Middle East conflicts affecting energy supplies. Practical reforms to this 15-member South-east Asian trade pact could enhance its effectiveness and regional benefits.

Key Points

• Middle East shipping disruptions severely impact Asia, which receives 84% of Hormuz Strait crude oil and 83% of LNG, driving up energy costs and inflation across the region.

• Asia lacks military solutions to such supply shocks, making institutional frameworks its primary defense against economic vulnerabilities.

• The Regional Comprehensive Economic Partnership (RCEP), a 15-member trade pact representing 30% of global GDP, serves as Asia’s strongest protective instrument.

The Vulnerability of Asia to Global Trade Disruptions

Asia’s heavy dependence on Middle Eastern energy makes it acutely vulnerable to geopolitical shocks. In 2024, 84 per cent of crude oil and condensate and 83 per cent of liquefied natural gas passing through the Strait of Hormuz were destined for Asian markets. Any conflict or disruption in that critical waterway translates almost immediately into higher energy costs, rising freight rates, and renewed inflationary pressures across the region, exposing the fragility of Asia’s supply chains and its limited ability to absorb external economic disruptions independently.

RCEP as Asia’s Strongest Institutional Shield

Since Asia lacks military capacity to counter such geopolitical shocks, its most reliable line of defense is institutional and economic rather than strategic. The Regional Comprehensive Economic Partnership (RCEP), a 15-member trade agreement, represents the region’s most powerful collective instrument. Accounting for approximately 30 per cent of global GDP, RCEP offers a framework through which member nations can coordinate responses, stabilize trade flows, and reinforce economic resilience. Strengthening this pact is therefore not merely a matter of trade policy but a critical element of regional security and stability in an increasingly volatile global environment.

Practical Reforms to Maximize RCEP’s Effectiveness

To fully realize RCEP’s protective potential, practical and meaningful reforms are essential. The agreement must evolve beyond its current structure to become more effective, inclusive, and operationally responsive to modern trade challenges. Streamlining regulations, reducing non-tariff barriers, and improving implementation mechanisms would significantly enhance the pact’s real-world impact. Member nations must commit to deeper cooperation and treat RCEP not as a static document but as a living framework capable of adapting to disruptions — whether from energy crises, shipping bottlenecks, or broader geopolitical realignments — ensuring the region’s long-term economic sovereignty and collective prosperity.

Other People are Reading

LOS ANGELES — Rita Wilson has opened up about the deeply personal requests she made to husband Tom Hanks during her 2015 breast cancer diagnosis and treatment, offering a rare glimpse into the emotional toll the disease took on their marriage and family while highlighting the couple’s enduring bond through crisis.

The actress and singer, married to Hanks since 1988, was diagnosed with invasive lobular carcinoma after a routine biopsy following an abnormal mammogram. She underwent a double mastectomy and reconstructive surgery, choosing to share her journey publicly to raise awareness. In a recent interview, Wilson recalled asking Hanks for two specific things as she faced uncertainty: to feel profound sadness on her behalf and to remain committed to their life together despite the challenges. “One is that you should be sad for a very, very long time,” she shared.

Wilson’s diagnosis came at a pivotal moment. The couple was promoting Hanks’ film “Bridge of Spies” when she received the news. She described the whirlwind of emotions — shock, fear and determination — that followed. Hanks was her rock, canceling commitments to be by her side. Wilson credits his unwavering support with helping her navigate surgery and recovery, emphasizing how their partnership deepened through adversity.

The requests Wilson made reflected her vulnerability. Asking Hanks to grieve alongside her acknowledged the shared impact of the diagnosis on their family. The second request, though less explicitly detailed in recent comments, centered on maintaining their life and love amid uncertainty. Wilson has spoken previously about the importance of emotional honesty in marriage during health crises, noting how Hanks’ presence provided strength without diminishing her own resilience.

The couple’s experience resonated widely when Wilson first shared her diagnosis in 2015. Her openness encouraged other women to prioritize screenings and seek early detection. Breast cancer remains one of the most common cancers among women, with survival rates improving significantly through advances in treatment. Wilson’s story highlighted the importance of family support systems in recovery journeys.

Wilson and Hanks have been married for nearly four decades, a Hollywood rarity. They first met on the set of the 1980s sitcom “Bosom Buddies” and reconnected years later. Their relationship has weathered career highs, public scrutiny and now health challenges. Wilson has described Hanks as her best friend and partner, crediting their strong foundation for helping them navigate her cancer battle.

Post-treatment, Wilson embraced a proactive approach to health. She has advocated for genetic testing, regular screenings and lifestyle choices supporting wellness. Her career continued with acting roles, producing and music projects, demonstrating resilience. She has used her platform to destigmatize cancer conversations, emphasizing hope and empowerment.

Hanks has spoken sparingly about the experience, respecting Wilson’s lead in sharing details. The Oscar winner has described the period as one of quiet strength and family unity. The couple’s two sons, Chet and Truman, were teenagers at the time, adding another layer of emotional complexity. Wilson has noted how the family grew closer through the ordeal.

The couple’s story aligns with broader trends in celebrity health advocacy. High-profile diagnoses often spark public awareness campaigns and increased screenings. Organizations like the American Cancer Society report surges in inquiries following announcements by stars like Wilson. Her willingness to discuss the emotional requests made to Hanks humanizes the experience beyond medical statistics.

Wilson’s recovery journey included physical rehabilitation and emotional processing. She has been candid about body image changes after mastectomy and reconstruction, challenging societal beauty standards. Her advocacy extends to supporting research and access to care, particularly for underserved communities. She has participated in fundraisers and awareness events, using her voice for positive impact.

Today, Wilson and Hanks continue sharing their lives with fans through projects and occasional public appearances. Wilson’s music career has flourished, with albums reflecting personal growth and resilience. The couple’s enduring partnership serves as inspiration, demonstrating how love and commitment can sustain through life’s most difficult chapters.

Medical experts praise Wilson’s approach as a model for patients. Open communication with partners, proactive health management and public advocacy can reduce isolation and stigma. Breast cancer treatment has advanced considerably since 2015, with personalized therapies improving outcomes. Wilson’s story remains relevant as a testament to hope and the power of support networks.

As Wilson reflects on that period, her message centers on resilience and gratitude. The heartbreaking requests made to Hanks during her battle underscore the emotional weight of serious illness on relationships. Yet their story ultimately highlights strength found in partnership, family and determination to move forward. Wilson’s openness continues inspiring others facing similar journeys, proving that vulnerability can coexist with power.

Here’s a look at how Bill Ackman’s newly listed stocks are performing since their public offering earlier this week—his Pershing Square hedge-fund management company (which carries the ticker PS) and his stock-picking fund Pershing Square USA (PSUS):

ENGLEWOOD, Colo. — Shares of Lightwave Logic Inc. skyrocketed more than 18 percent in morning trading Friday, climbing to around $16.19 as investors piled into the small-cap photonics company amid renewed enthusiasm for technologies that could ease the massive power and bandwidth demands of artificial intelligence data centers.

The surge pushed the stock’s market capitalization above $2 billion and came on heavy volume, reflecting broader excitement in AI-related infrastructure plays. Lightwave Logic, which develops proprietary electro-optic polymers designed to enable faster, lower-power optical data transmission, has been riding a wave of optimism tied to its progress integrating its technology into silicon photonics platforms used by major semiconductor foundries.

The company announced earlier this week that it had engaged Michael Best & Friedrich LLP as its strategic intellectual property advisor. The move is intended to strengthen its patent portfolio, support invention harvesting and prepare for expanded licensing agreements with foundries and design partners. Executives said the partnership will help create a more licensing-friendly framework as the company pushes its Perkinamine electro-optic polymer platform toward commercial adoption in high-speed modulators.

Lightwave Logic’s technology aims to solve a critical bottleneck in AI infrastructure. Traditional silicon photonics modulators struggle with power consumption and speed as data rates climb toward 200 and 400 gigabits per lane and beyond. The company’s polymers promise to deliver 110 gigahertz-plus performance at dramatically lower drive voltages, potentially slashing energy use in optical transceivers and co-packaged optics — components essential for connecting thousands of AI chips inside hyperscale data centers.

Analysts and industry watchers note the optical transceiver market is projected to reach $100 billion by 2030, driven almost entirely by AI demand. Lightwave Logic positions itself at the materials layer of that supply chain, supplying the specialty polymer that could replace or augment today’s indium phosphide or lithium niobate modulators.

Recent milestones have fueled investor confidence. In March, the company signed a development agreement with Tower Semiconductor to integrate its modulators into Tower’s PH18 silicon photonics platform. The program includes multiple engineering tape-outs scheduled for 2026 to validate 200G and 400G designs. Lightwave Logic has also made its high-speed modulator platform available in the GDSFactory process design kit for GlobalFoundries’ silicon photonics offering and maintains relationships with SilTerra and at least one additional unnamed foundry.

The company reported advancing four Fortune Global 500 customers into Stage 3 of its design-win cycle — the prototype-to-final-product phase. Management has said wafer tape-outs are underway and customer chips could return for testing as early as the second quarter of 2026. A recent technical program with a second major customer focuses on co-developing electro-optic polymer solutions tailored for next-generation data-center applications.

Financial results remain modest but show progress toward commercialization. For full-year 2025, Lightwave Logic posted revenue of roughly $237,000 — up 144 percent from the prior year — primarily from licensing and non-recurring engineering fees. Net loss narrowed to $20.3 million, or 16 cents per share. A December 2025 public offering bolstered the balance sheet to approximately $69 million in cash, giving the company runway into late 2027 without additional dilution, according to executives.

Chief Executive Officer Dr. Michael Lebby has repeatedly emphasized the transition from pure research to foundry-enabled manufacturing. The company’s Denver facility is ramping backend processes to support prototyping and eventual production scale-up targeted for 2027. Reliability data presented in recent investor materials showed the Perkinamine polymers passing stringent Telcordia 85/85 humidity and temperature tests when encapsulated in silicon photonics devices — a key hurdle for data-center qualification.

Still, the stock’s volatility underscores the speculative nature of the investment. Lightwave Logic has traded as low as 82 cents and as high as $15.29 in the past 52 weeks. Year-to-date gains exceeded 390 percent entering Friday, but the company remains pre-revenue in any meaningful sense and has a long history of development-stage delays common in advanced materials.

Wall Street coverage is limited. One analyst maintains a sell rating with no formal price target, citing execution risks and the lengthy design cycles in the semiconductor industry. CNBC’s Jim Cramer recently called the name “a perfect candidate for selling half your stock tomorrow morning,” noting the stock had already priced in much of the future story despite tiny current revenue and ongoing losses.

Supporters counter that the technology’s performance edge — sub-1-volt drive, ultra-low power and high bandwidth — aligns perfectly with the industry’s shift toward co-packaged optics and 1.6T and 3.2T transceivers. Successful commercialization could position Lightwave Logic as a critical materials supplier much like how certain specialty chemicals underpin today’s chip manufacturing.

Investors are also watching the upcoming annual shareholder meeting and any updates from 2026 tape-out results. Positive customer validation or first licensing revenue could catalyze further upside, while delays or disappointing reliability data in real-world silicon photonics environments could trigger sharp pullbacks.

Lightwave Logic was founded more than three decades ago and has spent years refining its polymer chemistry. The payoff, if it materializes, would come as AI training clusters require exponentially more optical interconnects. Hyperscalers including those behind the world’s largest AI models are pushing for optics inside the package to overcome copper’s limitations at extreme speeds.

Whether the stock represents a long-term buy depends heavily on execution over the next 12 to 24 months. Bulls see a multi-billion-dollar addressable market and first-mover advantage in a disruptive material. Bears highlight the binary risks of any early-stage technology company: regulatory hurdles, manufacturing scale-up challenges, potential competition from established photonics players and the ever-present possibility of further equity raises.

For now, the market is voting with its dollars. Friday’s 18 percent pop reflects fresh conviction that Lightwave Logic’s polymers could help solve one of AI’s thorniest engineering problems — moving massive amounts of data at the speed of light while keeping power consumption in check.

Company officials declined to comment beyond their public releases, directing inquiries to the investor relations website. Lightwave Logic shares closed Thursday at $13.72 before Friday’s open. The stock has no dividend and trades on Nasdaq under the ticker LWLG.

As the AI buildout accelerates, Lightwave Logic’s story is entering a make-or-break phase. Success in 2026 tape-outs and foundry qualifications could validate years of research and turn the pre-commercial bet into a core holding for growth-oriented technology investors. Failure to deliver on those milestones, however, would likely test even the most patient shareholders.

LOUISVILLE, Ky. — The 152nd Kentucky Derby is set for Saturday at Churchill Downs, with post time scheduled for 6:57 p.m. ET in the signature race of the Triple Crown season. A field of 20 three-year-olds will vie for the garland of roses in the $5 million Run for the Roses, promising one of the most anticipated — and heavily wagered — days in American sports.

Renegade, trained by Todd Pletcher and ridden by Irad Ortiz Jr., drew the rail and opened as the 4-1 morning-line favorite after an impressive Arkansas Derby victory. Other top contenders include Commandment and Further Ado at around 6-1, Chief Wallabee near 8-1, and So Happy and The Puma in single digits. Odds will fluctuate until race time as betting action intensifies.

The race shapes up as wide-open, with strong opinions on both sides of the favorite. Experts highlight a mix of speed, stamina and tactical versatility across the field, drawn from key prep races including the Florida Derby, Louisiana Derby, Blue Grass and others. Cool, dry conditions are forecast, favoring a fast track that could produce blistering times in the 1¼-mile classic.

Renegade brings elite credentials but faces the dreaded inside post, which historically challenges horses in large fields. Pletcher, a multiple Derby winner, has the colt sharp, yet some handicappers worry about rail position and early traffic. Commandment, from the Brad Cox barn, impressed in Florida and could stalk or close effectively with Luis Saez aboard. Further Ado, breaking from post 17 or 18, offers outside speed or mid-pack versatility depending on the early pace scenario.

Value plays abound. Emerging Market, trained by Chad Brown, has limited but high-quality starts and could offer a price around 15-1. Danon Bourbon represents strong Japanese influence and international interest at double-digit odds. Chief Wallabee, another Cox trainee, and The Puma, an improving Gustavo Delgado charge, also draw attention as potential upset candidates.

Jody Demling, who nailed a lucrative superfecta in a prior Derby, is among those fading the top choice. He points to The Puma’s consistency and a longshot “freak” with upside in exotics. Other experts, including those from BloodHorse and Horse Racing Nation, lean toward Commandment or Further Ado on top, with Emerging Market frequently appearing in top-three lists for its tactical flexibility.

The full projected field, subject to final scratches, features a blend of established stars and live longshots:

• Post 1: Renegade (4-1 to 5-1), Pletcher/Ortiz Jr. — Speedy Arkansas Derby winner but rail concerns loom.
• Post 6: Commandment (6-1 to 7-1), Cox/Saez — Florida form gives him a strong shot to stalk and pounce.
• Post ~17-18: Further Ado (6-1), strong closer with stamina for the distance.
• Post 9 or so: The Puma (5-1 to 10-1) — Late bloomer undefeated or near in recent starts.
• Chief Wallabee (8-1), So Happy (6-1), Danon Bourbon (~14-1), Emerging Market (~13-1) and others round out a competitive group.

Scratches have already adjusted the lineup, with horses like Fulleffort and Silent Tactic out, bringing in alternates such as Great White or Ocelli. The 20-horse gate ensures chaos, where post position, pace and jockey decisions often decide the outcome.

Handicapping angles focus on the Road to the Kentucky Derby points system, which qualified the top earners. Prep races highlighted closers and versatile types over pure speed. Brad Cox holds a powerful hand with multiple live contenders, while international bloodlines add depth. Weather and track bias will play roles — a dry forecast favors speed but middle and late runners have succeeded in recent editions.

Betting interest is expected to shatter records. Win bets on favorites, exactas, trifectas and superfectas will dominate, with exotic wagers offering massive payouts in a 20-horse scrum. TwinSpires and other platforms report heavy early action on Renegade, Commandment and value horses like Danon Bourbon.

Beyond the wagering, the Derby embodies tradition. Mint juleps, extravagant hats and celebrity sightings will fill the Churchill Downs infield and grandstand. The event kicks off a whirlwind May leading to the Preakness and Belmont, with potential for the first Triple Crown in years if a horse sweeps the series.

Experts’ consensus top picks vary but cluster around a few:

• Win contenders: Commandment or Further Ado for many, citing tactical advantages and proven stakes form.
• Place/show: The Puma, Chief Wallabee or Emerging Market for value.
• Longshots: Danon Bourbon, Incredibolt or Pavlovian could crash the exotics at big prices.

One prominent handicapper likes boxing Commandment, The Puma and a closer with Emerging Market underneath. Another emphasizes Florida preps and international upside with Danon Bourbon at 20-1 range. Fading the favorite entirely is a bold but discussed strategy given the rail and large field dynamics.

The Derby’s unpredictability is legendary — longshots like Rich Strike (80-1) and Country House (via disqualification) remind bettors that pedigree, training and race-day luck trump morning-line odds. This year’s class appears deep, with no runaway standout, setting up for a memorable stretch duel.

Churchill Downs officials emphasize safety and fan experience, with enhanced security and sustainability initiatives. NBC and Peacock will broadcast nationwide, bringing the pageantry to millions.

As horses ship in and final workouts conclude, anticipation builds. Renegade’s rail draw adds intrigue — can he overcome history? Will a closer steal the show in the final furlongs? Or does an overlooked mid-pack runner deliver the upset?

Whatever the result, the 2026 Kentucky Derby promises drama, high stakes and the enduring magic of the Sport of Kings. Bettors and fans alike will remember where they were when the gates spring open and the call of “And they’re off!” echoes through Louisville.

For those planning wagers, key strategies include focusing on horses with proven 1¼-mile stamina, favorable post positions away from the rail for traffic avoidance, and trainers with Derby success. Value exists beyond the top three morning-line choices, particularly in exotics where layering 8-1 to 20-1 horses can yield strong returns.

The Road to the Roses delivered a compelling group this year. From dominant prep wins to gritty recoveries, each contender has a story. On Saturday, only one will wear the roses — but the debate and memories will last far longer.

Post-race analysis will dissect every move, but pre-race, the consensus expert lean favors tactical versatility over pure favoritism. Commandment, Further Ado and live prices like Emerging Market or Chief Wallabee top many professional tickets.

The Kentucky Derby remains horse racing’s crown jewel, blending athletic excellence, strategy and sheer spectacle. This year’s edition, with its balanced field and star trainers, is poised to deliver.

HOUSTON — Kevin Durant will miss Game 6 of the Houston Rockets’ first-round playoff series against the Los Angeles Lakers on Friday night because of a bone bruise in his left ankle, sources told ESPN’s Shams Charania. The absence marks the fourth consecutive game the 37-year-old star has sat out, dealing a significant blow to Houston’s hopes of forcing a Game 7.

Durant suffered the injury in Game 2 on April 21 and has been sidelined since, missing the majority of the series despite playing in Game 1 after recovering from an earlier knee issue. The bone bruise requires a minimum two-week recovery period, and with Durant just over one week into the injury timeline, he remains unavailable as the Rockets attempt to stave off elimination while trailing 3-2.

The Rockets have shown resilience without their veteran leader, winning Games 4 and 5 to extend the series. Young talents like Alperen Sengun, Amen Thompson, Jabari Smith Jr., Reed Sheppard and Tari Eason have stepped up, forming one of the youngest starting lineups to secure playoff victories. Coach Ime Udoka’s group has controlled stretches of recent contests, giving fans reason for optimism despite the star’s absence.

Durant’s availability has been a major storyline throughout the postseason. He missed Game 1 with a tendon bruise before returning briefly, only to aggravate the ankle. The injury’s nature — a bone bruise — is notoriously stubborn, often lingering and affecting explosiveness and lateral movement critical to Durant’s game. At 37, with a lengthy career including four scoring titles, two Finals MVPs and an NBA championship, durability concerns have grown, though his scoring touch remains elite when healthy.

For the Lakers, Durant’s continued absence presents an opportunity to close out the series in Houston. LeBron James and company have navigated the series with mixed results, dropping the last two games at home but maintaining the series lead. Los Angeles will look to exploit Houston’s youth and inexperience in high-stakes moments, relying on veteran poise and defensive intensity to secure the win and advance.

Houston entered the playoffs as a dangerous lower seed, bolstered by Durant’s addition in the offseason. The move paired his scoring with a core of athletic, switchable defenders and versatile bigs. Regular-season success validated the roster construction, but playoff injuries have tested the depth. Without Durant, the Rockets rank among the youngest playoff teams relying on contributors still developing their games under pressure.

Medical experts note that bone bruises in the ankle involve micro-damage to the bone beneath cartilage, causing pain, swelling and reduced mobility. Recovery timelines vary but often extend beyond initial estimates, especially for high-usage wings like Durant who rely on change-of-direction speed. Rockets medical staff will monitor progress closely, but rushing back risks long-term complications or re-injury that could derail next season.

Series context adds drama. The Rockets became just the 16th team in NBA history to force a Game 6 after trailing 3-0, winning consecutive games without their leading scorer. Sengun has dominated the paint, Thompson provides defensive versatility and energy, and the supporting cast has executed Udoka’s schemes effectively. Still, Durant’s 25-plus points per game scoring and gravity as a shooter create mismatches that younger players struggle to replicate fully.

Lakers stars have commented on the challenge of facing Houston’s depth. James, in his 23rd season, understands the value of veteran presence in the postseason. Anthony Davis anchors the defense, while supporting pieces like Austin Reaves and Rui Hachimura provide balance. Los Angeles aims to end the series Friday to avoid a potential Game 7 back home, where Houston’s home-court energy could complicate matters.

Durant’s playoff history is storied. From Oklahoma City to Golden State, Brooklyn and Phoenix, he has delivered iconic performances. His move to Houston represented a chance at another deep run with a young, hungry squad. This injury, however, underscores the physical toll of a long career and the demands of playoff basketball. Fans and analysts debate whether the Rockets’ future is brighter with or without the veteran, but his presence undeniably elevates their ceiling.

Broader NBA implications ripple from the series. A Rockets victory extends the first-round slate and tests Lakers’ stamina ahead of a tougher second-round matchup. An elimination accelerates Los Angeles’ preparations while allowing Houston to evaluate its young core’s growth. Durant’s status also affects offseason narratives around load management, veteran acquisitions and injury prevention league-wide.

Rockets fans have mixed emotions. Many express frustration over the timing of the injury but praise the team’s fight. Social media buzzes with support for the young players and calls for Durant’s careful management. Team officials remain optimistic about his long-term health, emphasizing a measured return rather than risking further damage in a best-of-seven that could end soon.

Game 6 strategy without Durant likely involves heavier minutes for Sengun in the post, Thompson’s athleticism on the wings, and increased ball-handling from guards. Defensive schemes will focus on containing James and Davis while forcing turnovers. The Lakers, conversely, will push pace, attack mismatches and leverage experience in crunch time.

Injury reports will be monitored until tip-off, but all indications point to Durant sidelined. Pre-game warmups and official announcements will confirm, yet sources close to the situation see little chance of a last-minute change given the two-week minimum timeline.

The NBA playoffs thrive on such storylines — star absences creating opportunities for unlikely heroes. Whether Houston’s youth can pull off another improbable win or the Lakers close the door remains to be seen. Durant’s absence shifts the narrative but does not eliminate the Rockets’ competitive spirit.

As the series reaches a critical juncture, focus turns to execution on the floor. Houston plays for pride and extension; Los Angeles seeks advancement. Durant’s recovery timeline could stretch into a potential Game 7 or beyond, leaving the Rockets to rely on collective effort in his stead.

The basketball world watches closely. Kevin Durant’s legacy endures, but for Game 6, the spotlight belongs to those stepping into the void. Rockets fans hope their young core delivers magic once more, while Lakers supporters anticipate a series-clinching victory on the road.